Skip to main content

Table 1 Baseline characteristics of the studies included in the meta-analysis

From: The preventive effect of atorvastatin on atrial fibrillation: a meta-analysis of randomized controlled trials

Study, year

n

Population

Dosage

Duration

Endpoint

Documentation of AF

Quality score

MIRACL 2004 [13]

3087

Acute coronary syndrome

80 mg/d

16 weeks

New onset or recurrence of AF

Follow-up with ECG

5

Dernellis et al. 2005 [14]

80

Paroxysmal AF

20–40 mg/d

4–6 months

Recurrence of AF

48-h ambulatory ECG monitoring

3

Chello et al. 2006 [15]

40

Coronary bypass surgery

20 mg/d

3 weeks

New-onset AF after cardiac surgery

ECG monitoring

4

Ozaydin et al. 2006 [16]

48

Persistent AF and scheduled EC

10 mg/d

3 months

Recurrence of AF

24-h ambulatory ECG monitoring

2

ARMYDA-3 2006 [17]

200

Cardiac surgery

40 mg/d

30 days

New-onset AF after cardiac surgery

ECG monitoring after the operation, then follow-up with ECG

5

Tsai et al. 2008 [18]

106

Bradyarrhythmia and implantation of pacemaker

20 mg/d

1 year

AF/AHE ≥ 10 min

Pacemaker interrogation

2

Song et al. 2008 [19]

124

Off-pump coronary bypass surgery

20 mg/d

30 days

New-onset AF after cardiac surgery

ECG monitoring after the operation, then follow-up with ECG

3

Almroth et al. 2009 [20]

234

Persistent AF and scheduled EC

80 mg/d

30 days

Recurrence of AF

Follow-up with ECG

5

Melina et al. 2009 [21]

632

Coronary bypass surgery

40 mg/d

Not mentioned

New-onset AF after cardiac surgery

Not mentioned

2

Ji et al. 2009 [22]

140

Off-pump coronary bypass surgery

20 mg/d

13 days

New-onset AF after cardiac surgery

ECG monitoring or 12-lead ECG

5

Spadaccio et al. 2010 [23]

50

Coronary bypass surgery

20 mg/d

7 days

New-onset AF after cardiac surgery

ECG monitoring

4

Sun et al. 2011 [24]

100

Coronary bypass surgery

20 mg/d

14 days

New-onset AF after cardiac surgery

ECG monitoring

3

SToP AF 2011 [25]

64

Persistent AF and scheduled EC

80 mg/d

12 months

Recurrence of AF

Follow-up with ECG and 24-h ambulatory ECG monitoring

5

SPARCL 2011 [26]

4731

Prior stroke or transient ischemic attack

80 mg/d

4.8 years

New-onset AF

Follow-up with ECG

5

Demir et al. 2011 [27]

48

Persistent AF and scheduled EC

40 mg/d

2 months

Recurrence of AF

Weekly follow-up with ECG

2

Baran et al. 2012 [28]

60

Coronary bypass surgery

40 mg/d

30 days

New-onset AF after cardiac surgery

ECG monitoring after the operation, then follow-up with ECG

5

Suleiman et al. 2012 [29]

125

AF undergoing catheter ablation

80 mg/d

3 months

Recurrence of AF

Follow-up with ECG and 72-h ambulatory ECG monitoring

4

Jiang et al. 2013 [30]

101

AF undergoing catheter ablation

40 mg/d

6 months

Recurrence of AF

Not mentioned

2

  1. AF: atrial fibrillation; AHE: Atrial high rate episode; ARMYDA-3: Atorvastatin for Reduction of MYocardial Dysrhythmia After cardiac surgery study; EC: Electrical cardioversion; ECG: Electrocardiogram; MIRACL: Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering study; SPARCL: Stroke Prevention by Aggressive Reduction in Cholesterol Levels; SToP AF: statin therapy for the prevention of atrial fibrillation trial.